Back to search
FDAFDA · Food and drugs·Recall number Z-0834-2024

ENDOPATH ECHELON 45mm RELOADS WITH GRIPPING SURFACE TECHNOLOGY (GST), ECHELON Endopath Stapler, Endoscopic Linear Cutter Reload (+Gripping Surface technology), 45MM WHITE VASCULAR/THIN, Product No. GST45W

Published February 7, 2024 · Recall initiated: December 11, 2023

Summary

FDA records medical device Class II recall Z-0834-2024, published February 7, 2024 and initiated December 11, 2023. Recalling firm: Ethicon Endo-Surgery Inc; Status: Ongoing; Reported quantity: 22,616 (US), 4,476 (OUS); Lot: UDI-DI 10705036014928 Lots 442C02 and 442C03. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is the potential for incomplete staple line formation during the firing sequence, without most or all staples, which may lead to insufficient tissue apposition that could require surgical intervention. This may result in bleeding, prolonged surgery, or surgical delay.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ethicon Endo-Surgery Inc
Distributor
Worldwide distribution - US Nationwide and the countries of Canada and Brazil.
Lot
UDI-DI 10705036014928 Lots 442C02 and 442C03
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ENDOPATH ECHELON 45mm RELOADS WITH GRIPPING SURFACE TECHNOLOGY (GST), ECHELON Endopath Stapler, Endoscopic Linear Cutter Reload (+Gripping Surface technology), 45MM WHITE VASCULAR/THIN, Product No. GST45W recalled?

Yes. FDA published recall Z-0834-2024 on February 7, 2024. Reported hazard: There is the potential for incomplete staple line formation during the firing sequence, without most or all staples, which may lead to insufficient tissue apposition that could require surgical intervention. This may result in bleeding, prolonged surgery, or surgical delay.

What should I do if I have this product?

Voluntary: Firm initiated · Letter